Gimbal Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-11,300
Closed -$183K 48
2024
Q4
$183K Buy
+11,300
New +$9.36M 0.15% 47

Other funds holding LLY

Gimbal Financial's LLY Position: Q3 2025 in Review

Gimbal Financial reduced its Eli Lilly (LLY) stake by 18% in Q3 2025, selling an estimated $2.28M and leaving 14,094 shares worth $10.8M. The position accounts for 6.46% of the portfolio, ranked #7.

Gimbal Financial first reported a position in LLY in Q4 2023 and has held it in 8 quarters since. The position peaked at $17M in Q2 2024. 3,898 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Gimbal Financial held 14,094 shares of Eli Lilly worth $10.8M as of Q3 2025.
  • Gimbal Financial sold 3,066 Eli Lilly shares in Q3 2025, an estimated $2.28M.
  • Eli Lilly made up 6.46% of Gimbal Financial's portfolio in Q3 2025, its #7 holding.
  • Gimbal Financial first reported a position in Eli Lilly in Q4 2023 and has held it in 8 quarters since.
  • Gimbal Financial's Eli Lilly position peaked at $17M in Q2 2024.
  • 3,898 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Gimbal Financial's 13F filing for Q3 2025, filed 4 Nov 2025.